← Back to All Filings

GIC Private Ltd Sells $274.8M in Medline Inc. (MDLN) Common Stock

High SignificanceOctober 13, 2026 at 1:37:46 PM UTC

Medline Inc.

$MDLN4CIK: 0002046386

Subscribe to track MDLN

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

🚨 Large Insider Sale: Medline Inc. ($MDLN) Insider: GIC Private Ltd (10% Owner) Action: Sold 7,816,987 shares of Class A Common Stock at $35.15/share Total Value: $274,767,093.05 Ownership After: 69,408,506 indirect shares (plus 16,453,806 direct shares) Filing Date: October 13, 2026

Comprehensive Analysis

Transaction Analysis: Medline Inc. ($MDLN)

Overview

On October 13, 2026, GIC Private Ltd, together with its affiliated entities GIC Special Investments Pte Ltd and Hux Investment Pte. Ltd., filed a Form 4 disclosing a massive open-market or secondary transaction in Medline Inc. ($MDLN) Class A Common Stock.

Key Details

  • Date of Transaction: October 8, 2026
  • Shares Sold: 7,816,987 shares
  • Execution Price: $35.15 per share
  • Total Gross Proceeds: $274,767,093.05
  • Ownership Post-Transaction: Following the sale, Hux Investment Pte. Ltd. holds 69,408,506 shares indirectly on behalf of GIC, with an additional 16,453,806 shares held directly by reporting entities.

Context and Significance

This transaction carries High significance due to the substantial dollar amount ($274.8 million). Sovereign wealth fund affiliates such as GIC often execute structured secondary sales or partial profit-taking following corporate transactions or IPO lock-up expirations. Despite disposing of nearly 7.82 million shares, GIC entities retain an overwhelming combined stake exceeding 85.8 million shares, remaining key institutional stakeholders in Medline Inc.

Topics:#MDLN#Medline#GIC#InsiderTrading#SECForm4

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.